Please log in to view this page
Username
Password
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
